18-00-2023
The article announces advancements in health monitoring through technology developed by the Polish company IQ Biozoom. Supported by the venture capital fund VC Link, the company is working on non-invasive devices for measuring biochemical substances in the body, such as glucose and lactates, using saliva analysis.
IQ Biozoom is developing technology that promises laboratory-level accuracy in biomarker measurements without the discomfort associated with traditional invasive glucose meters. The new device utilizes stream-printed biosensors and can measure various biochemical substances using disposable test strips.
Although this technology is not yet commercially available, it has the potential to reduce the discomfort associated with measurements and improve access to home diagnostics. The company plans to continue developing and certifying its devices while collaborating with international research and clinical centers.
IQ Biozoom is currently in its seed investment round and anticipates further growth in the home diagnostics market, which is expanding rapidly.
For further details, you can read more here (Cukrzyca.pl)
IQ Biozoom introduces revolutionary medical innovations with its biosensing platform. We develop non-invasive, pain-free saliva-based tests to monitor various civilisation diseases, providing easy access to health information.
Get more info about IQ Biozoom Technology
Interesting in our science publications? Contact us to get the links.
Meet us:
